Wird geladen...
Phase II Cancer Clinical Trials with Heterogeneous Patient Populations
The patient population for a phase II trial often consists of multiple subgroups in terms of risk level. In this case, a popular design approach is to specify the response rate and the prevalence of each subgroup, to calculate the response rate of the whole population by the weighted average of the...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3324125/ https://ncbi.nlm.nih.gov/pubmed/22251176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2010.536873 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|